Get the Stockscreener App
0.347
1.79%
-0.00632
Femasys Inc stock is traded at $0.347, with a volume of 1.37M.
It is down -1.79% in the last 24 hours and down -32.64% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.3533
Open:
$0.3575
24h Volume:
1.37M
Relative Volume:
1.25
Market Cap:
$11.30M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-0.4181
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
-3.56%
1M Performance:
-32.64%
6M Performance:
-78.31%
1Y Performance:
-69.29%
1-Day Range:
$0.34
$0.3575
1-Week Range:
$0.34
$0.37
52-Week Range:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.347 | 11.51M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
438.60 | 159.16B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
180.78 | 53.33B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
267.27 | 40.15B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
73.35 | 37.08B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
255.25 | 18.69B | 2.96B | 487.70M | 344.00M | 6.68 |
Femasys Inc Stock (FEMY) Latest News
Femasys Inc. Partners with Kebomed to Expand FemBloc Permanent Birth Control Availability in France and Benelux Region - Quiver Quantitative
Femasys announces partnership with Kebomend to commercialize FemBloc - TipRanks
First Non-Surgical Permanent Birth Control: Femasys' FemBloc Launches Major European Expansion - Stock Titan
Femasys partners with Medical Electronic Systems for FemSperm kit - Yahoo Finance
Femasys partners with MES to launch sperm analysis kit By Investing.com - Investing.com Nigeria
Comparing Femasys Inc. in custom built stock radarsMarket Growth Summary & Real-Time Sentiment Analysis - newser.com
Technical signs of recovery in Femasys Inc.July 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Femasys partners with MES to launch sperm analysis kit - Investing.com India
How to track smart money flows in Femasys Inc.2025 Market Outlook & Growth Focused Investment Plans - newser.com
Femasys Inc. recovery potential after sell offEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
Femasys Inc. Partners with Medical Electronic Systems to Launch FemSperm Analysis Kit, Enhancing In-Office Infertility Treatment - Quiver Quantitative
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed - GlobeNewswire
2X Higher Pregnancy Rates: Femasys Expands FemSperm Line for Revolutionary FemaSeed Fertility Treatment - Stock Titan
Critical Comparison: PDS Biotechnology (NASDAQ:PDSB) and Femasys (NASDAQ:FEMY) - Defense World
Market Pulse: Is Femasys Inc stock undervalued right nowEarnings Recap Summary & Daily Profit Focused Stock Screening - خودرو بانک
Setup Watch: Will Femasys Inc. benefit from current market trendsQuarterly Trade Report & Technical Confirmation Trade Alerts - خودرو بانک
Using flow based indicators on Femasys Inc.Earnings Summary Report & Community Driven Trade Alerts - newser.com
What MACD and RSI say about Femasys Inc.Earnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Short interest data insights for Femasys Inc.Weekly Profit Analysis & Technical Confirmation Alerts - newser.com
Buy Signal: Can ARCT stock double in the next yearJuly 2025 Trade Ideas & Step-by-Step Swing Trade Plans - khodrobank.com
Market Outlook: Is Femasys Inc. a turnaround storyQuarterly Trade Review & Precise Entry and Exit Recommendations - khodrobank.com
Key metrics from Femasys Inc.’s quarterly dataMarket Performance Recap & Stock Portfolio Risk Management - newser.com
Is Femasys Inc benefiting from interest rate changesQuarterly Profit Review & Low Risk High Win Rate Picks - خودرو بانک
Femasys Inc. stock trend outlook and recovery path2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Can trapped investors hope for a rebound in Femasys Inc.Forecast Cut & Safe Capital Allocation Plans - newser.com
Options Flow: Is Femasys Inc stock undervalued right nowJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - خودرو بانک
Detecting support and resistance levels for Femasys Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Femasys stock falls after pricing capital raise of $8M via securities offering - MSN
Volatility Watch: Is Femasys Inc a momentum stockJobs Report & Capital Efficient Trade Techniques - خودرو بانک
How institutional ownership impacts Femasys Inc. stockEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Aug Setups: Can Femasys Inc. deliver consistent dividendsWeekly Profit Recap & Free Growth Oriented Trading Recommendations - khodrobank.com
Stock Market Recap: Is Femasys Inc. a potential multi baggerWeekly Investment Summary & Short-Term High Return Strategies - khodrobank.com
Will Femasys Inc. price bounce be sustainablePortfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Chart based exit strategy for Femasys Inc.2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Femasys Attracts $8 Million in Funding - Medical Product Outsourcing
Femasys Inc. Expands FemSperm?? Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemSeed - MarketScreener
Femasys Inc. Launches FemSperm Insemination Prep Kit to Enhance Accessibility of Fertility Treatments - Quiver Quantitative
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® - The Manila Times
Femasys expands FemSperm product line with Insemination Prep Kit - TipRanks
10M Women Could Benefit: Femasys Launches Game-Changing Fertility Kit for Gynecologist Offices - Stock Titan
Femasys Expands FemSperm™ Product Line with New - GlobeNewswire
Femasys Gains UK Approval for FemBloc Birth Control - MSN
Merger Talk: Is Femasys Inc. a turnaround storyJuly 2025 Fed Impact & Stock Market Timing Techniques - 뉴스영
Femasys Inc. Receives MEDSAFE Approval for FemBloc Permanent Birth Control in New Zealand, Expanding Global Access to Innovative Women's Health Solutions - Quiver Quantitative
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand - GlobeNewswire
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):